NPL has announced the resignation of Mr. Pravin Shetty from his positions as Chief Financial Officer (CFO) and Chief Risk Officer (CRO). The company made this disclosure in compliance with regulatory obligations.

Resignation Details

Mr. Shetty tendered his resignation on September 15, 2025, citing personal reasons. According to the company's filing, his last working day is scheduled for September 19, 2025. This information was conveyed to the stock exchange as part of National Peroxide's regulatory requirements under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Company's Statement

In the official communication, National Peroxide Limited stated:

"Mr. Pravin Shetty, Chief Financial Officer (CFO), Chief Risk Officer (CRO) of the Company, has tendered his resignation from the post of CFO & CRO, due to personal exigencies. His last working day with the organisation will be September 19, 2025."

Regulatory Compliance

The company has provided the necessary disclosures as required by SEBI regulations, including details of the change in key managerial personnel. This transparency ensures that shareholders and potential investors are kept informed about significant changes within the organization's leadership.

About National Peroxide Limited

National Peroxide Limited, formerly known as NPL Chemicals Limited, is a company registered under CIN: L24290MH2020PLC342890. The company's registered office is located at Neville House, J. N. Heredia Marg, Ballard Estate, Mumbai - 400 001.

As the company begins the process of identifying a successor for the CFO and CRO positions, stakeholders will be keenly watching for further announcements regarding the appointment of new key managerial personnel.

National Peroxide Limited (NPL), India's largest manufacturer of hydrogen peroxide, has reported a challenging fiscal year 2024-25, with a net loss of ₹224.64 crore compared to a profit of ₹1,679.03 crore in the previous year. The company has scheduled its 5th Annual General Meeting (AGM) for September 4, 2025, to be held virtually.

Financial Performance

NPL's financial results for FY 2024-25 show:

The company attributed the loss to increased competition and new capacity expansion in the hydrogen peroxide industry, leading to oversupply and drastic price cutting by new entrants. Additionally, challenging international conditions made exporting hydrogen peroxide difficult, affecting exports by 50%.

Dividend

Given the financial performance, the Board of Directors has decided not to declare any dividend for FY 2024-25, in contrast to the previous year when a dividend of ₹12.50 per share was paid.

Future Outlook and Strategic Initiatives

Despite the current challenges, NPL is implementing several strategic initiatives to improve its performance:

1. Expanding and exploring export markets for hydrogen peroxide
2. Maintaining Net Sales Realization (NSR) in the domestic market
3. Implementing a hybrid solar and wind project to reduce electricity costs
4. Streamlining manpower requirements and focusing on cost-saving initiatives
5. Identifying cost efficiency projects to improve margins
6. Exploring new business opportunities in the chemical industry

For FY 2025-26, NPL is targeting:

• Production and sales of 120,000 MT (96% of capacity, 7% increase from FY 2024-25)
• Sales of approximately ₹320 crore
• Estimated Profit Before Tax of ₹1 crore

Annual General Meeting Details

The 5th AGM of National Peroxide Limited is scheduled for September 4, 2025, at 3:30 PM IST via video conferencing. Key agenda items include:

1. Adoption of audited financial statements for FY 2024-25
2. Re-appointment of Dr. Minnie Bodhanwala as director
3. Ratification of remuneration for cost auditors
4. Appointment of M/s. Parikh & Associates as secretarial auditors
5. Re-appointment of Mr. Rajiv Arora as Whole-Time Director and CEO

Shareholders can participate in the AGM through the virtual platform provided by NSDL. The remote e-voting period will be from September 1 to September 3, 2025.

As NPL navigates through these challenging times, the company remains focused on operational excellence, cost optimization, and exploring new growth opportunities to return to profitability in the coming years.